Bio Path Holdings, Inc. financial data

Symbol
BPTH on Nasdaq
Industry
Pharmaceutical Preparations
Location
4710 Bellaire Boulevard, Suite 210, Bellaire, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
OGDEN GOLF CO CORP (to 2/19/2008)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 104 % -82.3%
Debt-to-equity -914 % -3731%
Return On Equity 2.62K %
Return On Assets -322 % -86.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.31M shares -65.1%
Common Stock, Shares, Outstanding 3.71M shares -67.6%
Entity Public Float 13.5M USD -51%
Common Stock, Value, Issued 4K USD -63.6%
Weighted Average Number of Shares Outstanding, Basic 3.02M shares +500%
Weighted Average Number of Shares Outstanding, Diluted 3.02M shares +500%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 7.75M USD -36.4%
General and Administrative Expense 4.65M USD +0.98%
Operating Income (Loss) -12.4M USD +26.2%
Nonoperating Income (Expense) 1.89M USD +574%
Net Income (Loss) Attributable to Parent -10.5M USD +36.9%
Earnings Per Share, Basic -10.1 USD/shares +84.9%
Earnings Per Share, Diluted -10.1 USD/shares +84.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Other Assets, Current 1.81M USD -0.66%
Assets, Current 2.9M USD -39.6%
Property, Plant and Equipment, Net 42K USD -54.3%
Operating Lease, Right-of-Use Asset 24K USD -81.1%
Assets 2.97M USD -40.9%
Accounts Payable, Current 1.04M USD +274%
Accrued Liabilities, Current 2.31M USD +140%
Liabilities, Current 3.38M USD +149%
Operating Lease, Liability, Noncurrent 3K USD -96.5%
Liabilities 3.68M USD +47.3%
Retained Earnings (Accumulated Deficit) -115M USD -10.1%
Stockholders' Equity Attributable to Parent -712K USD -128%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -712K USD -128%
Liabilities and Equity 2.97M USD -40.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.27M USD
Net Cash Provided by (Used in) Financing Activities 7.22M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 3.71M shares -67.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.95M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 562K USD -76.1%
Deferred Tax Assets, Valuation Allowance 24.2M USD +26.3%
Deferred Tax Assets, Gross 24.2M USD +26.1%
Operating Lease, Liability 113K USD -48.9%
Depreciation 28K USD
Lessee, Operating Lease, Liability, to be Paid 119K USD -50.4%
Property, Plant and Equipment, Gross 1.12M USD 0%
Operating Lease, Liability, Current 26K USD -77.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11K USD -89.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 108K USD -10.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6K USD -68.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11K USD -85.5%
Deferred Tax Assets, Operating Loss Carryforwards 18.6M USD +17.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 114M USD +6.82%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 21K USD -50%
Share-based Payment Arrangement, Expense 900K USD 0%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%